Aprogen Biologics Inc. logo

Aprogen Biologics Inc. (003060)

Market Closed
12 Jun, 06:30
KRX SM KRX SM
2,575. 00
+75
+3%
119.53B Market Cap
- P/E Ratio
- Div Yield
37,369 Volume
- Eps
2,500
Previous Close
Add Transaction
Day Range
2,500 2,655
Year Range
2,490 10,719.64
Want to track 003060 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

003060 closed Friday higher at ₩2,575, an increase of 3% from Thursday's close, completing a monthly decrease of -20.0311% or -₩645. Over the past 12 months, 003060 stock gained 396.1464%.
003060 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -41.124%, based on the last three reports.
Aprogen Biologics Inc. has completed 9 stock splits, with the recent split occurring on Apr 13, 2026.
The company's stock is traded on one exchange.

003060 Chart

People also search for

Tk Chemical Corp.
1,792
+1.4723%
H.S. Industries Co. Ltd.
2,780
+1.0909%
Motrex Co. Ltd.
7,020
+1.1527%
BYC Co Limited Preferred Stock
25,550
+0.9881%
Digital Daesung Co., Ltd.
7,860
-0.3802%

Aprogen Biologics Inc. (003060) FAQ

What is the stock price today?

The current price is ₩2,575.00.

On which exchange is it traded?

Aprogen Biologics Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 003060.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 119.53B.

Has Aprogen Biologics Inc. ever had a stock split?

Aprogen Biologics Inc. had 9 splits and the recent split was on Apr 13, 2026.

Aprogen Biologics Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Jeong-Chool Kim CEO
KRX SM Exchange
KR7003060001 ISIN
KR Country
391 Employees
- Last Dividend
13 Apr 2026 Last Split
- IPO Date

Overview

Aprogen Biologics Inc. is a South Korean pharmaceutical company, established in 1960, with its headquarters located in Seongnam-si. The company is engaged in the manufacture and sale of a diverse portfolio of pharmaceutical products within the local market. It prides itself on offering a wide range of medicines, spanning both ethical (prescription) drugs and over-the-counter (OTC) treatments, catering to various medical needs and conditions. With a focus on innovation and excellence in the pharmaceutical field, Aprogen Biologics Inc. is committed to improving patient care and health outcomes.

Products and Services

Aprogen Biologics Inc.’s product lineup covers a vast range of therapeutic areas, including:

  • Transfusion Products: Medicines and solutions used in medical transfusions.
  • Digestive System Treatments: Drugs aimed at improving gastrointestinal health and treating conditions such as ulcers and acid reflux.
  • Osteoarthritis and Skeletal Muscle Relaxants: Medications to alleviate pain and improve mobility in conditions like osteoarthritis.
  • NSAIDs and Osteoporosis Treatments: Nonsteroidal anti-inflammatory drugs for pain and inflammation, and treatments to strengthen bones and prevent fractures.
  • Circulatory System Medications: Drugs that support heart health and improve circulation.
  • Endocrine Treatments: Medications for disorders of the endocrine system, including diabetes and thyroid conditions.
  • Respiratory System Treatments: Drugs to alleviate respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).
  • Urinary System Medications: Treatments for urinary tract infections (UTIs) and other urological conditions.
  • Depilatory, Antihistamines, and Antiallergics: Products for hair removal, allergy relief medications, and treatments for allergic reactions.
  • Obesity and Brain Function Enhancers: Treatments for weight management and drugs to support cognitive functions.
  • Neurologic Agents: Medications for neurological conditions such as epilepsy and Parkinson's disease.
  • Male Pattern Hair Loss Treatments: Drugs specifically designed to combat hair loss in men.
  • Anti-biotic, Anti-fungal, and Anti-viral Agents: A range of drugs to combat infections caused by bacteria, fungi, and viruses.
  • Anti-ulcerant and Anti-epilepsy Products: Treatments for peptic ulcers and seizure control.
  • External Agents: Topically applied medications for a variety of skin conditions and wounds.
  • Anti-cancer Drugs: A wide array of chemotherapy agents targeting different types of cancer.
  • Amino-acid Nutrient Transfusion Agents: Supplements and solutions to aid in nutritional support, especially for patients requiring intravenous nutrition.
  • Cosmetics: A selection of beauty and skin care products, blending pharmaceutical expertise with cosmetic needs.

Contact Information

Address: Halla Sigma Valley 442-2, Seongnam-si, South Korea
Phone: 82 2 561 4011